Kemin Pharma

Kemin Pharma is the pharmaceutical division of Kemin Industries, a global ingredient manufacturer headquartered in Des Moines, Iowa. The company focuses on the discovery and development of novel small molecule therapeutics derived from natural botanical sources, leveraging the parent company's expertise in specialty crop improvement. Kemin Pharma's research primarily targets chronic inflammatory and autoimmune conditions, utilizing a proprietary library of plant-based compounds to identify bioactive molecules. Their lead clinical candidate, KEM7001, is a small molecule derivative investigated for the treatment of psoriasis and other inflammatory disorders. By integrating molecular biology with advanced plant science, Kemin Pharma aims to bridge the gap between nutritional science and pharmaceutical intervention.